These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 2142749)
1. Acute nonlymphocytic leukemia after transient myeloproliferative disorder in a patient with Down syndrome. Barnett PL; Clark AC; Garson OM Med Pediatr Oncol; 1990; 18(5):347-53. PubMed ID: 2142749 [TBL] [Abstract][Full Text] [Related]
2. Congenital transient myeloproliferative disorder progressing to acute myeloid leukemia in Down's syndrome: a case report. Prabhu PD; V G; Niveditha SR; Gayathri BR; Keshavamurthy SR Indian J Pathol Microbiol; 2004 Jan; 47(1):48-50. PubMed ID: 15471129 [TBL] [Abstract][Full Text] [Related]
3. Transient myeloproliferative disorder in neonates with and without Down syndrome: a tale of 2 syndromes. Apollonsky N; Shende A; Ouansafi I; Brody J; Atlas M; Aygun B J Pediatr Hematol Oncol; 2008 Nov; 30(11):860-4. PubMed ID: 18989165 [TBL] [Abstract][Full Text] [Related]
4. Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome. Kanegane H; Watanabe S; Nomura K; Xu G; Ito E; Miyawaki T Int J Hematol; 2007 Oct; 86(3):250-2. PubMed ID: 17988992 [TBL] [Abstract][Full Text] [Related]
5. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome. Brissette MD; Duval-Arnould BJ; Gordon BG; Cotelingam JD Am J Hematol; 1994 Dec; 47(4):316-9. PubMed ID: 7977305 [TBL] [Abstract][Full Text] [Related]
6. Transient myeloproliferative disorder and GATA1 mutation in neonates with and without Down syndrome. Tsai MH; Hou JW; Yang CP; Yang PH; Chu SM; Hsu JF; Chiang MC; Huang HR Indian J Pediatr; 2011 Jul; 78(7):826-32. PubMed ID: 21287369 [TBL] [Abstract][Full Text] [Related]
7. Transient myeloproliferative disorder in Down syndrome presenting with ascites: a case report. Shiffer J; Natarajan S Acta Cytol; 2001; 45(4):610-2. PubMed ID: 11480727 [TBL] [Abstract][Full Text] [Related]
8. Hematological disorders and leukemia in children with Down syndrome. Bruwier A; Chantrain CF Eur J Pediatr; 2012 Sep; 171(9):1301-7. PubMed ID: 22113227 [TBL] [Abstract][Full Text] [Related]
9. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia. Alford KA; Reinhardt K; Garnett C; Norton A; Böhmer K; von Neuhoff C; Kolenova A; Marchi E; Klusmann JH; Roberts I; Hasle H; Reinhardt D; Vyas P; Blood; 2011 Aug; 118(8):2222-38. PubMed ID: 21715302 [TBL] [Abstract][Full Text] [Related]
10. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review. D'Angelo G; Merlo P Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826 [TBL] [Abstract][Full Text] [Related]
11. Infants with Down's syndrome. Use of cytogenetic studies and in vitro colony assay for granulocyte progenitor to distinguish acute nonlymphocytic leukemia from a transient myeloproliferative disorder. de Alarcon PA; Patil S; Golberg J; Allen JB; Shaw S Cancer; 1987 Sep; 60(5):987-93. PubMed ID: 2955884 [TBL] [Abstract][Full Text] [Related]
12. Transient myeloproliferative disorder and acute nonlymphoblastic leukemia in Down syndrome. Wong KY; Jones MM; Srivastava AK; Gruppo RA J Pediatr; 1988 Jan; 112(1):18-22. PubMed ID: 2961859 [TBL] [Abstract][Full Text] [Related]
13. Transient myeloproliferative disorder associated with trisomy 21, a wide range syndrome: report of two cases with trisomy 21 mosaicism. Zubizarreta P; Muriel FS; Fernández Barbieri MA Med Pediatr Oncol; 1995 Jul; 25(1):60-4. PubMed ID: 7753004 [TBL] [Abstract][Full Text] [Related]
14. Transient myeloproliferative disorder and acute myeloid leukemia: study of six neonatal cases with long-term follow-up. Liang DC; Ma SW; Lu TH; Lin ST Leukemia; 1993 Oct; 7(10):1521-4. PubMed ID: 8412314 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Hayashi Y; Eguchi M; Sugita K; Nakazawa S; Sato T; Kojima S; Bessho F; Konishi S; Inaba T; Hanada R Blood; 1988 Jul; 72(1):15-23. PubMed ID: 2968822 [TBL] [Abstract][Full Text] [Related]
16. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome. Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818 [TBL] [Abstract][Full Text] [Related]